Litigation

Recent Posts

Amylin Sues Eli Lilly Over Diabetes Drug Development Deal
Posted on 17 May 2011 by LexisNexis Litigation Resource Community Staff

INDIANAPOLIS - (AP) Amylin Pharmaceuticals Inc. said Monday it filed a lawsuit against Eli Lilly and Co., accusing the larger drugmaker of breaking their commercialization deal for diabetes drugs by teaming with the German company Boehringer Ingelheim... Read More